(Total Views: 445)
Posted On: 06/30/2020 11:30:50 AM
Post# of 61
$GALT News Article - UPDATE -- Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin in NASH Cirrhosis https://marketwirenews.com/news-releases/upda...03312.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
